As far as the current medical research is concerned, hypertension is divided into primary hypertension and secondary hypertension. So-called primary hypertension simply means hypertension for which no cause can be found, while secondary hypertension refers to hypertension secondary to other diseases or causes. Its clinical manifestations, complications and consequences are similar to those of primary hypertension, which accounts for about 5% to 10% of the hypertensive population. Elevated blood pressure is only one clinical manifestation of these diseases. However, many patients with hypertension do not know where the cause is, but in fact there is another “hidden” cause, namely hypertension caused by renal artery stenosis. Only when a patient is examined by a doctor, the real cause is identified early and treated promptly, can his blood pressure be truly and effectively controlled. Do not blindly take all kinds of antihypertensive drugs without permission, causing multiple physical and mental injuries. Not all hypertension requires lifelong medication, and there is a secondary hypertension that requires only a small intervention to get rid of the medication and avoid the many hazards associated with hypertension. There are many such cases in the Department of Vascular Surgery of Yangzhou First People’s Hospital, which are constantly creating “miracles”. The patient Zhu, 54 years old, had a history of hypertension for more than 20 years, and his blood pressure had been poorly controlled during medication. The operation was over in less than an hour with little trauma, and the patient recovered well from blood pressure after the operation and got rid of a lot of drugs. According to Prof. Sun Peng, stenosis of one or both renal arteries and their branches caused by various etiologies can cause renal vascular hypertension, which is a kind of secondary hypertension, accounting for about 5% to 10% of adult hypertension, and the occurrence of hypertension due to kidney lesions, and hypertension can cause kidney damage, and the two will promote each other, which will make the disease further develop and worsen. In this type of hypertension, drug treatment is not effective, while minimally invasive interventional treatment can have an immediate effect. Professor Peng Sun said that intractable hypertension caused by renal artery stenosis can occur at any age, and the possibility of renal vascular hypertension is often suggested in patients with one of the following conditions: (1) systolic or diastolic murmur heard in the epigastrium; (2) first diastolic blood pressure above 115 mmHg, or sudden worsening of previously diagnosed essential hypertension; (3) hypertension in very young patients, or women under 50 years of age; (4) severe hypertension with episodes soon after age 50; (5) malignant hypertension; (6) hypertension resistant to commonly used medical therapy; and (7) worsening renal function after initiation of antihypertensive agents (especially angiotensin-converting enzyme [ACE] inhibitors). If you have the above symptoms, you must visit a professional vascular surgery department and undergo relevant examinations. If you are found to have severe renal artery stenosis, you can take appropriate minimally invasive treatment methods, so that you can get rid of the daily big pills and get rid of hypertensive disease. The Department of Vascular Surgery of Yangzhou First People’s Hospital, a domestic leader in the diagnosis and treatment of renal vascular hypertension with rich clinical practice experience, has successfully relieved many hypertensive patients of their pain and restored their health through intracavitary minimally invasive treatment, and eliminated the pain of long-term oral antihypertensive drugs. Currently, percutaneous transluminal angioplasty (PTA) and percutaneous renal artery stenting (STENT) are the first-line treatments for renal vascular hypertension. Their complications are significantly reduced compared to surgical procedures. They are effective in improving hypertension and can improve renal function in 30% to 40% of patients. Surgical revascularization is also available for patients who are not candidates for endoluminal treatment by: aorto-renal artery bypass graft, hepatic-renal artery bypass graft, splenic-renal artery bypass graft, iliac-renal artery bypass graft, and renal autograft.